Fig. 4From: Role of inflammatory burden and treatment on joint space width in psoriatic arthritis—a high-resolution peripheral quantitative computed tomography studyDifferences in minimum JSW according to treatment. *p < 0.05. A csDMARDs; B bDMARDs. Patients receiving csDMARDs (MCPJ 3) and bDMARDs (MCPJ 2–3) had significantly lower and higher Min JSW respectively, compared to non-users. JSW, joint space width; MCPJ, metacarpophalangeal; csDMARDs, conventional synthetic disease-modifying anti-rheumatic drugs; bDMARDs, biologic disease-modifying anti-rheumatic drugsBack to article page